Drug
Lanthanum Carbonate
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Appendicitis | 270 | 123.2 | 130.1 | signal |
| 2 | Ventricular Fibrillation | 246 | 93.0 | 97.7 | signal |
| 3 | Cardiogenic Shock | 259 | 76.1 | 80.2 | signal |
| 4 | Multiple Organ Dysfunction Syndrome | 285 | 42.5 | 45.0 | signal |
| 5 | End Stage Renal Disease | 178 | 40.2 | 41.6 | signal |
| 6 | Ascites | 280 | 39.6 | 41.8 | signal |
| 7 | Incorrect Route Of Product Administration | 156 | 38.6 | 39.8 | signal |
| 8 | Hyperlipidaemia | 102 | 35.4 | 36.1 | signal |
| 9 | Bacterial Infection | 157 | 35.1 | 36.2 | signal |
| 10 | Aspiration | 79 | 30.3 | 30.7 | signal |
| 11 | Ulcer | 105 | 27.3 | 27.9 | signal |
| 12 | Neuralgia | 150 | 25.6 | 26.4 | signal |
| 13 | Gout | 100 | 23.1 | 23.5 | signal |
| 14 | Hyponatraemia | 295 | 21.7 | 23.0 | signal |
| 15 | Blood Test Abnormal | 71 | 20.9 | 21.2 | signal |
| 16 | Peritonitis | 99 | 19.8 | 20.2 | signal |
| 17 | Hypercholesterolaemia | 45 | 19.5 | 19.6 | signal |
| 18 | Full Blood Count Abnormal | 47 | 18.4 | 18.6 | signal |
| 19 | Ileus | 53 | 17.8 | 18.0 | signal |
| 20 | Micturition Urgency | 46 | 16.8 | 16.9 | signal |
| 21 | Stress | 281 | 16.2 | 17.0 | signal |
| 22 | Sepsis | 368 | 13.6 | 14.6 | signal |
| 23 | Hypocalcaemia | 62 | 13.6 | 13.7 | signal |
| 24 | Peritonitis Bacterial | 33 | 13.5 | 13.6 | signal |
| 25 | Chronic Obstructive Pulmonary Disease | 160 | 12.7 | 13.1 | signal |
| 26 | Dialysis | 43 | 12.5 | 12.6 | signal |
| 27 | Blood Cholesterol Increased | 140 | 12.4 | 12.7 | signal |
| 28 | Abdominal Distension | 309 | 12.3 | 13.0 | signal |
| 29 | General Physical Health Deterioration | 334 | 12.0 | 12.8 | signal |
| 30 | Transaminases Increased | 60 | 11.2 | 11.3 | signal |
| 31 | Coronary Artery Disease | 74 | 10.0 | 10.1 | signal |
| 32 | Prescribed Overdose | 45 | 9.6 | 9.7 | signal |
| 33 | Joint Injury | 48 | 9.3 | 9.3 | signal |
| 34 | Sudden Death | 24 | 9.3 | 9.3 | signal |
| 35 | Cerebral Infarction | 54 | 9.1 | 9.2 | signal |
| 36 | Joint Range Of Motion Decreased | 29 | 9.0 | 9.0 | signal |
| 37 | Blood Calcium Decreased | 24 | 8.8 | 8.8 | signal |
| 38 | Cardiovascular Disorder | 54 | 8.7 | 8.8 | signal |
| 39 | Diabetes Mellitus | 158 | 8.5 | 8.8 | signal |
| 40 | Dry Mouth | 165 | 8.4 | 8.7 | signal |
| 41 | Thrombosis | 163 | 8.3 | 8.6 | signal |
| 42 | Melaena | 44 | 8.2 | 8.3 | signal |
| 43 | Sleep Disorder | 133 | 7.8 | 8.0 | signal |
| 44 | Wrong Technique In Drug Usage Process | 70 | 7.8 | 7.9 | signal |
| 45 | Constipation | 377 | 7.2 | 7.7 | signal |
| 46 | Intentional Product Misuse | 148 | 7.0 | 7.2 | signal |
| 47 | Sputum Discoloured | 16 | 7.0 | 7.0 | signal |
| 48 | Liver Function Test Increased | 36 | 7.0 | 7.0 | signal |
| 49 | Transient Ischaemic Attack | 57 | 6.9 | 7.0 | signal |
| 50 | Myocardial Ischaemia | 19 | 6.8 | 6.9 | signal |
| 51 | Lower Respiratory Tract Infection | 75 | 6.8 | 6.9 | signal |
| 52 | Swelling | 154 | 6.8 | 7.0 | signal |
| 53 | Gastric Ulcer | 31 | 6.7 | 6.8 | signal |
| 54 | Hypercalcaemia | 20 | 6.7 | 6.7 | signal |
| 55 | Pulmonary Embolism | 152 | 6.6 | 6.7 | signal |
| 56 | Abdominal Pain | 365 | 6.5 | 6.9 | signal |
| 57 | Drug Intolerance | 147 | 6.3 | 6.5 | signal |
| 58 | Iron Deficiency Anaemia | 14 | 6.3 | 6.3 | signal |
| 59 | Obstructive Airways Disorder | 17 | 6.3 | 6.3 | signal |
| 60 | Blood Creatinine Increased | 99 | 6.2 | 6.3 | signal |
| 61 | Myoclonus | 18 | 6.2 | 6.2 | signal |
| 62 | Anaemia | 282 | 6.1 | 6.4 | signal |
| 63 | Pneumonia Aspiration | 36 | 6.0 | 6.0 | signal |
| 64 | Pleural Effusion | 87 | 5.9 | 6.0 | signal |
| 65 | Intestinal Perforation | 16 | 5.9 | 5.9 | signal |
| 66 | Pulmonary Mass | 21 | 5.8 | 5.8 | signal |
| 67 | Altered State Of Consciousness | 30 | 5.7 | 5.8 | signal |
| 68 | Deformity | 13 | 5.7 | 5.7 | signal |
| 69 | Blood Potassium Increased | 22 | 5.6 | 5.6 | signal |
| 70 | Fluid Overload | 20 | 5.6 | 5.6 | signal |
| 71 | Thrombotic Microangiopathy | 13 | 5.5 | 5.5 | signal |
| 72 | Liver Disorder | 59 | 5.5 | 5.5 | signal |
| 73 | Haemoptysis | 37 | 5.5 | 5.5 | signal |
| 74 | Scar | 22 | 5.3 | 5.3 | signal |
| 75 | Arteriosclerosis | 12 | 5.2 | 5.3 | signal |
| 76 | Intestinal Obstruction | 47 | 5.2 | 5.2 | signal |
| 77 | Diverticulitis | 34 | 5.1 | 5.1 | signal |
| 78 | Anhedonia | 32 | 5.0 | 5.0 | signal |
| 79 | Hyperkalaemia | 42 | 5.0 | 5.0 | signal |
| 80 | Skin Ulcer | 31 | 5.0 | 5.0 | signal |
| 81 | Upper Respiratory Tract Infection | 55 | 4.9 | 5.0 | signal |
| 82 | Aspartate Aminotransferase Increased | 63 | 4.9 | 4.9 | signal |
| 83 | Cholecystitis | 14 | 4.9 | 4.9 | signal |
| 84 | Gastroenteritis | 17 | 4.8 | 4.8 | signal |
| 85 | Device Related Infection | 18 | 4.8 | 4.8 | signal |
| 86 | Pulmonary Fibrosis | 22 | 4.7 | 4.8 | signal |
| 87 | Hepatic Function Abnormal | 42 | 4.7 | 4.7 | signal |
| 88 | Musculoskeletal Stiffness | 99 | 4.7 | 4.7 | signal |
| 89 | Economic Problem | 17 | 4.5 | 4.6 | signal |
| 90 | Somnolence | 219 | 4.5 | 4.6 | signal |
| 91 | Acute Myocardial Infarction | 32 | 4.5 | 4.5 | signal |
| 92 | Oedema Peripheral | 131 | 4.4 | 4.5 | signal |
| 93 | Cardiomegaly | 13 | 4.3 | 4.3 | signal |
| 94 | Vomiting | 480 | 4.2 | 4.6 | signal |
| 95 | Chronic Kidney Disease | 78 | 4.2 | 4.2 | signal |
| 96 | Cardiac Failure | 80 | 4.1 | 4.2 | signal |
| 97 | Disseminated Intravascular Coagulation | 14 | 4.1 | 4.1 | signal |
| 98 | Pulmonary Congestion | 13 | 4.0 | 4.1 | signal |
| 99 | Subarachnoid Haemorrhage | 10 | 4.0 | 4.0 | signal |
| 100 | Neurotoxicity | 17 | 4.0 | 4.0 | signal |
| 101 | Subdural Haematoma | 14 | 4.0 | 4.0 | signal |
| 102 | Mitral Valve Incompetence | 11 | 4.0 | 4.0 | signal |
| 103 | Hepatic Encephalopathy | 9 | 4.0 | 4.0 | signal |
| 104 | Coronary Artery Occlusion | 13 | 3.9 | 3.9 | signal |
| 105 | Lung Disorder | 43 | 3.6 | 3.6 | signal |
| 106 | Renal Failure | 116 | 3.6 | 3.6 | signal |
| 107 | Cardiac Arrest | 71 | 3.5 | 3.6 | signal |
| 108 | Condition Aggravated | 255 | 3.5 | 3.6 | signal |
| 109 | Arrhythmia | 40 | 3.5 | 3.5 | signal |
| 110 | Drug Hypersensitivity | 160 | 3.4 | 3.5 | signal |
| 111 | Quality Of Life Decreased | 11 | 3.4 | 3.4 | signal |
| 112 | Haemorrhoids | 16 | 3.4 | 3.4 | signal |
| 113 | Tooth Fracture | 9 | 3.4 | 3.4 | signal |
| 114 | Joint Stiffness | 21 | 3.3 | 3.3 | signal |
| 115 | Angina Pectoris | 23 | 3.3 | 3.3 | signal |
| 116 | Motor Dysfunction | 8 | 3.3 | 3.3 | signal |
| 117 | Septic Shock | 34 | 3.2 | 3.3 | signal |
| 118 | Pericardial Effusion | 18 | 3.2 | 3.2 | signal |
| 119 | Death | 673 | 3.2 | 3.6 | signal |
| 120 | Hypertension | 165 | 3.2 | 3.3 | signal |
| 121 | Gastric Haemorrhage | 9 | 3.2 | 3.2 | signal |
| 122 | Gastritis | 20 | 3.1 | 3.1 | signal |
| 123 | Blood Thyroid Stimulating Hormone Increased | 7 | 3.1 | 3.1 | signal |
| 124 | Cerebral Haemorrhage | 27 | 3.1 | 3.1 | signal |
| 125 | Blood Pressure Decreased | 50 | 3.1 | 3.1 | signal |
| 126 | Localised Infection | 18 | 3.1 | 3.1 | signal |
| 127 | Drug Administration Error | 23 | 3.0 | 3.1 | signal |
| 128 | Colon Cancer | 11 | 3.0 | 3.0 | signal |
| 129 | Posterior Reversible Encephalopathy Syndrome | 7 | 3.0 | 3.0 | signal |
| 130 | Gastrointestinal Disorder | 65 | 3.0 | 3.1 | signal |
| 131 | Tendon Rupture | 9 | 3.0 | 3.0 | signal |
| 132 | Cardio-respiratory Arrest | 30 | 2.9 | 2.9 | signal |
| 133 | Blood Urea Increased | 12 | 2.9 | 2.9 | signal |
| 134 | Carpal Tunnel Syndrome | 10 | 2.9 | 2.9 | signal |
| 135 | Haematemesis | 18 | 2.9 | 2.9 | signal |
| 136 | Agranulocytosis | 13 | 2.9 | 2.9 | signal |
| 137 | Cholelithiasis | 23 | 2.9 | 2.9 | signal |
| 138 | Cellulitis | 35 | 2.9 | 2.9 | signal |
| 139 | Gastrointestinal Haemorrhage | 58 | 2.8 | 2.9 | signal |
| 140 | Multi-organ Failure | 12 | 2.8 | 2.8 | signal |
| 141 | Bacteraemia | 8 | 2.8 | 2.8 | signal |
| 142 | Pancreatitis Acute | 15 | 2.8 | 2.8 | signal |
| 143 | Hypoxia | 23 | 2.7 | 2.7 | signal |
| 144 | Encephalopathy | 16 | 2.7 | 2.7 | signal |
| 145 | Nephropathy | 6 | 2.6 | 2.6 | signal |
| 146 | Eosinophilia | 11 | 2.6 | 2.6 | signal |
| 147 | Nausea | 493 | 2.6 | 2.7 | signal |
| 148 | Depressed Level Of Consciousness | 24 | 2.5 | 2.5 | signal |
| 149 | Osteomyelitis | 11 | 2.5 | 2.5 | signal |
| 150 | Ventricular Tachycardia | 10 | 2.5 | 2.5 | signal |
| 151 | Renal Injury | 18 | 2.5 | 2.5 | signal |
| 152 | Pruritus Generalised | 13 | 2.4 | 2.4 | signal |
| 153 | Mobility Decreased | 42 | 2.4 | 2.4 | signal |
| 154 | Convulsion | 34 | 2.4 | 2.4 | signal |
| 155 | Gamma-glutamyltransferase Increased | 13 | 2.4 | 2.4 | signal |
| 156 | Unresponsive To Stimuli | 15 | 2.4 | 2.4 | signal |
| 157 | Peripheral Coldness | 8 | 2.4 | 2.4 | signal |
| 158 | Drug Eruption | 10 | 2.3 | 2.3 | signal |
| 159 | Decreased Activity | 6 | 2.3 | 2.3 | no signal |
| 160 | Gastric Cancer | 14 | 2.3 | 2.3 | signal |
| 161 | Haemoglobin Decreased | 56 | 2.2 | 2.3 | signal |
| 162 | Urosepsis | 5 | 2.2 | 2.2 | no signal |
| 163 | Mental Status Changes | 15 | 2.2 | 2.2 | signal |
| 164 | Erythema Multiforme | 5 | 2.2 | 2.2 | no signal |
| 165 | Grand Mal Convulsion | 5 | 2.2 | 2.2 | no signal |
| 166 | Upper Gastrointestinal Haemorrhage | 9 | 2.2 | 2.2 | signal |
| 167 | Hypotension | 105 | 2.2 | 2.2 | signal |
| 168 | Myocardial Infarction | 92 | 2.2 | 2.2 | signal |
| 169 | Cardiac Failure Congestive | 42 | 2.1 | 2.1 | signal |
| 170 | Hypoglycaemia | 25 | 2.1 | 2.1 | signal |
| 171 | Skin Lesion | 14 | 2.1 | 2.1 | signal |
| 172 | Abdominal Pain Lower | 13 | 2.1 | 2.1 | signal |
| 173 | Hospitalisation | 78 | 2.1 | 2.1 | signal |
| 174 | Skin Discolouration | 23 | 2.1 | 2.1 | signal |
| 175 | Product Use In Unapproved Indication | 122 | 2.1 | 2.1 | signal |
| 176 | Muscle Tightness | 8 | 2.0 | 2.0 | no signal |
| 177 | Pancreatitis | 26 | 2.0 | 2.0 | signal |
| 178 | Asthma | 55 | 2.0 | 2.0 | signal |
| 179 | Haematochezia | 27 | 2.0 | 2.0 | signal |
| 180 | Drug-induced Liver Injury | 15 | 2.0 | 2.0 | signal |
| 181 | Cholestasis | 9 | 1.9 | 1.9 | no signal |
| 182 | Tremor | 77 | 1.9 | 1.9 | no signal |
| 183 | Faeces Discoloured | 10 | 1.9 | 1.9 | no signal |
| 184 | Gastric Disorder | 16 | 1.9 | 1.9 | no signal |
| 185 | Product Physical Issue | 9 | 1.9 | 1.9 | no signal |
| 186 | Femur Fracture | 14 | 1.9 | 1.9 | no signal |
| 187 | Skin Disorder | 15 | 1.9 | 1.9 | no signal |
| 188 | Product Taste Abnormal | 6 | 1.8 | 1.8 | no signal |
| 189 | Fistula | 5 | 1.8 | 1.8 | no signal |
| 190 | Status Epilepticus | 5 | 1.8 | 1.8 | no signal |
| 191 | Treatment Noncompliance | 24 | 1.8 | 1.8 | no signal |
| 192 | Shock | 10 | 1.8 | 1.8 | no signal |
| 193 | Respiratory Arrest | 12 | 1.8 | 1.8 | no signal |
| 194 | Pancytopenia | 24 | 1.8 | 1.8 | no signal |
| 195 | Coordination Abnormal | 6 | 1.8 | 1.8 | no signal |
| 196 | Fracture | 8 | 1.7 | 1.7 | no signal |
| 197 | Covid-19 Pneumonia | 5 | 1.7 | 1.7 | no signal |
| 198 | Blood Pressure Fluctuation | 10 | 1.7 | 1.7 | no signal |
| 199 | Injury | 28 | 1.6 | 1.6 | no signal |
| 200 | Bone Marrow Failure | 8 | 1.6 | 1.6 | no signal |
| 201 | Emotional Distress | 47 | 1.6 | 1.6 | no signal |
| 202 | International Normalised Ratio Increased | 11 | 1.6 | 1.6 | no signal |
| 203 | Pharmaceutical Product Complaint | 10 | 1.6 | 1.6 | no signal |
| 204 | Hallucination, Auditory | 6 | 1.6 | 1.6 | no signal |
| 205 | Blood Creatine Phosphokinase Increased | 11 | 1.5 | 1.6 | no signal |
| 206 | Jaundice | 10 | 1.5 | 1.5 | no signal |
| 207 | Acute Hepatic Failure | 5 | 1.5 | 1.5 | no signal |
| 208 | Abasia | 9 | 1.5 | 1.5 | no signal |
| 209 | Unevaluable Event | 27 | 1.5 | 1.5 | no signal |
| 210 | Lymphopenia | 5 | 1.5 | 1.5 | no signal |
| 211 | Anaphylactic Shock | 9 | 1.4 | 1.4 | no signal |
| 212 | Muscle Rigidity | 4 | 1.4 | 1.4 | no signal |
| 213 | Cardiac Disorder | 31 | 1.4 | 1.4 | no signal |
| 214 | Hepatitis C | 4 | 1.3 | 1.3 | no signal |
| 215 | Blood Count Abnormal | 5 | 1.3 | 1.3 | no signal |
| 216 | No Therapeutic Response | 4 | 1.3 | 1.3 | no signal |
| 217 | Personality Change | 3 | 1.3 | 1.3 | no signal |
| 218 | Skin Fissures | 6 | 1.3 | 1.3 | no signal |
| 219 | Skin Exfoliation | 26 | 1.3 | 1.3 | no signal |
| 220 | Interstitial Lung Disease | 15 | 1.3 | 1.3 | no signal |
| 221 | Activities Of Daily Living Impaired | 6 | 1.2 | 1.2 | no signal |
| 222 | Toxic Skin Eruption | 3 | 1.2 | 1.2 | no signal |
| 223 | Helicobacter Infection | 3 | 1.2 | 1.2 | no signal |
| 224 | Lung Neoplasm Malignant | 12 | 1.2 | 1.2 | no signal |
| 225 | Product Quality Issue | 39 | 1.2 | 1.2 | no signal |
| 226 | Device Occlusion | 4 | 1.2 | 1.2 | no signal |
| 227 | Diabetes Mellitus Inadequate Control | 5 | 1.2 | 1.2 | no signal |
| 228 | Diabetic Ketoacidosis | 6 | 1.0 | 1.0 | no signal |
| 229 | Hepatic Cytolysis | 3 | 1.0 | 1.0 | no signal |
| 230 | Osteonecrosis | 8 | 1.0 | 1.0 | no signal |
| 231 | Cytomegalovirus Infection | 4 | 1.0 | 1.0 | no signal |
| 232 | Overdose | 50 | 1.0 | 1.0 | no signal |
| 233 | No Adverse Event | 39 | 0.9 | 0.9 | no signal |
| 234 | Drug Prescribing Error | 4 | 0.8 | 0.8 | no signal |
| 235 | Wrong Technique In Product Usage Process | 38 | 0.8 | 0.8 | no signal |
| 236 | Plasma Cell Myeloma | 7 | 0.7 | 0.7 | no signal |
| 237 | Drug Effect Incomplete | 6 | 0.7 | 0.7 | no signal |
| 238 | Renal Cancer | 7 | 0.6 | 0.6 | no signal |
| 239 | Device Dislocation | 5 | 0.5 | 0.5 | no signal |
| 240 | Gynaecomastia | 3 | 0.4 | 0.4 | no signal |
| 241 | Incorrect Route Of Drug Administration | 3 | 0.3 | 0.3 | no signal |
| 242 | Prostate Cancer | 6 | 0.3 | 0.3 | no signal |
| 243 | Bladder Cancer | 3 | 0.2 | 0.2 | no signal |